Boulder biotech makes deal with industry giant

A Boulder biotech said it's made a deal with an industry giant to develop drugs for autoimmune disorders. Array BioPharma Inc. (Nasdaq: ARRY) said it's made a deal with giant Amgen Inc. (Nasdaq: AMGN) of Thousand Oaks, California to take advantage of Array's inflammatory disease discoveries. "The identification of this novel target, along with our team's deep experience in kinase inhibitor chemistry, gives us confidence that our efforts will result in a drug which will address a significant unmet…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news